• Explore /
  • Poster
  • / Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

Abstract Poster

Authors

Stephen Luen

Stephen James Luen

Peter MacCallum Cancer Centre, Melbourne, Australia

Stephen James Luen , Roberto Salgado , Maria Vittoria Dieci , Andrea Vingiani , Giuseppe Curigliano , Rebekah Hubbard , Carlos Castaneda Altamirano , Joselyn Sanchez , Timothy D'Alfonso , Esther Cheng , Miluska Castillo Garcia , Sylvia Adams , Fahad Ahmed , David L. Rimm , Sandra Demaria , William Fraser Symmans , Stefan Michiels , Sherene Loi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Neoadjuvant Therapy

Citation

J Clin Oncol 36, 2018 (suppl; abstr 571)

DOI

10.1200/JCO.2018.36.15_suppl.571

Abstract #

571

Poster Bd #

63

Abstract Disclosures

Similar Posters

First Author: Germán Corredor

First Author: William M. Sikov

First Author: Roberto Antonio Leon-Ferre

First Author: Cheng Wang